Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?∗

Por Biykem Bozkurt, MD, PhD
Publicado em 2020-01-01

Endpoints in Heart Failure Drug Development

Por Aliza Hussain, Arunima Misra, Biykem Bozkurt
Publicado em 2022-01-01

Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap

Por Nosheen Reza, Jadry Gruen, Biykem Bozkurt
Publicado em 2022-01-01

Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations

Por Vivek Patel, Ernesto Jimenez, Lorraine Cornwell, Trung Tran, David Paniagua, Ali E. Denktas, Andrew Chou, Samuel J. Hankins, Biykem Bozkurt, Todd K. Rosengart, Hani Jneid
Publicado em 2020-07-01

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

Por Sukhdeep S. Basra, Tracy Y. Wang, DaJuanicia N. Simon, Karen Chiswell, Salim S. Virani, Mahboob Alam, Vijay Nambi, Ali E. Denktas, Anita Deswal, Biykem Bozkurt, Christie M. Ballantyne, Eric D. Peterson, Hani Jneid
Publicado em 2018-06-01